Zephyr Health provides a SaaS platform that aggregates global healthcare data to help biopharmaceutical and medical device companies manage product lifecycle performance, from clinical trials to market strategy and sales. The company serves customers including Genentech, Gilead, Medtronic, Onyx and Amgen. Founded in 2011 by CEO William King, Zephyr is based in San Francisco and also has offices in London and Pune. The company intends to use new funding to further expand the business with new products and into new areas. Financially, Zephyr has raised a total of $33.5M to date. The platform is positioned as insights-as-a-service for healthcare enterprises. Founded by William King in 2011 after mining Johnson & Johnson’s datasets, Zephyr Health combines NoSQL databases, machine‑learning algorithms and data visualization into a suite of proprietary apps designed for life‑sciences workflows. Its apps let customers view trial responses, identify target institutions and drill into physician profiles to speed research and commercialization. The company has converted "five of the world’s largest pharmaceutical and device companies" into paying customers, validating its approach. After two and a half years of bootstrapping, Zephyr raised institutional capital to scale. The new funding will be used to ramp hiring—particularly in engineering—and to increase marketing efforts among industry players. Zephyr positions itself beyond simple data integration by linking datasets into context‑specific scenarios for R&D and go‑to‑market decisions.

Total raised

$33M

Funding rounds

2

Latest round

Series C

Latest activity

Aug 2015